Ameriprise
OCGN icon

Ameriprise’s Ocugen OCGN Stock Holding History

Ameriprise’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.7K Buy
15,850
+275
+2% +$476 ﹤0.01% 4023
2025
Q4 		$21K Buy
+15,575
New +$22.2K ﹤0.01% 4061
2025
Q2 		– Sell
-38,102
Closed -$26.9K – 4086
2025
Q1 		$26.9K Buy
38,102
+557
+1% +$385 ﹤0.01% 3967
2024
Q4 		$30.2K Buy
+37,545
New +$34.4K ﹤0.01% 4033
2023
Q1 		– Sell
-35,758
Closed -$46K – 4012
2022
Q4 		$46K Sell
35,758
-90
-0.3% -$140 ﹤0.01% 3866
2022
Q3 		$63K Sell
35,848
-8,200
-19% -$20.4K ﹤0.01% 3876
2022
Q2 		$100K Sell
44,048
-5,615
-11% -$13.4K ﹤0.01% 3781
2022
Q1 		$164K Sell
49,663
-1,710
-3% -$6.01K ﹤0.01% 3787
2021
Q4 		$233K Sell
51,373
-35,485
-41% -$268K ﹤0.01% 3750
2021
Q3 		$624K Buy
86,858
+5,300
+6% +$38.9K ﹤0.01% 3332
2021
Q2 		$655K Buy
81,558
+56,800
+229% +$479K ﹤0.01% 3366
2021
Q1 		$168K Buy
+24,758
New +$165K ﹤0.01% 3723

Other funds holding OCGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Ameriprise's OCGN Position: Q1 2026 in Review

Ameriprise increased its Ocugen (OCGN) stake by 1.8% in Q1 2026, buying an estimated $476 and bringing the position to 15,850 shares worth $28.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4023.

Ameriprise first reported a position in OCGN in Q1 2021 and has held it in 12 quarters since. The position peaked at $655K in Q2 2021. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • Ameriprise held 15,850 shares of Ocugen worth $28.7K as of Q1 2026.
  • Ameriprise bought 275 Ocugen shares in Q1 2026, an estimated $476.
  • Ocugen made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #4023 holding.
  • Ameriprise first reported a position in Ocugen in Q1 2021 and has held it in 12 quarters since.
  • Ameriprise's Ocugen position peaked at $655K in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.